
Cerentry Bio
Cerentry has developed a proprietary brain shuttle designed to enable transport of systemically administered therapeutics across the brain’s protective barriers and deliver drugs to the brain.
Brain disorders are prevalent and impact billions of people across the globe. They pose a major health burden. Despite advances, treatments remain limited due to the brain barriers that prevent therapeutic agents from reaching the brain.
Copenhagen
News about Cerentry Bio
No news stories yet
Published stories about this company will appear here.